Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
CARDIAC ARRHYTHMIA Catherine Seger Medicinal Chemistry TOPICS COVERED • Types of Arrhythmias – Ventricular • Cardiac Action Potential • Ion Channels of Interest • Classification of Anti-arrhythmic drugs • Drugs and Re-entry • Class I Drugs • Class III Drugs • Side Effects • Alternative Treatments and Future Drug Development MECHANISMS OF CARDIAC ARRHYTHMIAS •Triggered •Automatic •Normal •Abnormal •Re-entrant VENTRICULAR RE-ENTRY •Abnormal pattern of depolarization through the heart •Functional •Anatomic THE CARDIAC ACTION POTENTIAL ION CHANNELS RELEVENT TO THE CARDIAC ACTION POTENTIAL Antiarrhythmic Drug Pathways THE VAUGHAN WILLIAMS CLASSIFICATION SYSTEM OF ANTIARRHYTHMIC DRUGS Class Basic Mechanism I-Sodium Channel Blockade Reduce phase 0 slope and peak of action potential IA Moderate reduction in phase 0 slope; increase APD; increase ERP IB Small reduction in phase 0 slope; reduce APD; decrease ERP IC Pronounced reduction in phase 0 slope; no effect on APD or ERP II-Beta-blockade Delay repolarization (phase 3) and thereby increase action potential duration and effective refractory period. III-potassium-channel blockade Prolongation of APD and increase ERP; no effect on phase 0 IV-Calcium channel blockade Block L-type calcium-channels; most effective at SA and AV nodes; reduce rate and conduction. HOW THESE DRUGS AFFECT RE-ENTRY • Class I: retards conduction enough so that beat still gets through normal cardiac tissue but not through any weakened tissue • Class III: prolongs refractoriness CLASS I • IA – moderate • IB – weakest • IC – strongest CLASS IA CLASS IA-Procainamide Procainamide N-Acetyl Procainamide CLASS IB CLASS IB-Lidocaine CLASS IC CLASS IC-flecainide Cardiac Side Effects-Proarrhythmia •Potential re-entrant circuit can be turned into an actual re-entrant circuit • Increased incidence of death in the case of myocardial infarction Class III CLASS III-Sotalol Torsades des Pointes •Long Q-T syndrome •Polymorhic Ventricular Tachycardia •IA drugs can also cause this •Blocking of potassium channels and prolonging repolarization ALTERNATIVE TREATMENTS • Ablation • Implanantable Cardioverter Defibrillators (ICDs) ICD Placement In the Heart FUTURE OF DRUG DEVELOPMENT • Drugs with defibrillating effects – Sotalol – Tedisamil •Sympathomimetic-modulates cAMP •Protects Gap junctions and enhances Ca2+ uptake by SR • Drugs affecting Ion Channelopathy – hyperphosphorylation • Drugs or Devices? Antiarrhythmic Drug Pathways